Evidence map›Paper›PMID 38480824›Full record

ArticleNature human behaviour2024

The prevalence of cardiovascular disease risk factors among adults living in extreme poverty.

Pascal Geldsetzer, Rebecca L Tisdale, Lisa Stehr, Felix Michalik, Julia Lemp, Krishna K Aryal, Albertino Damasceno, Corine Houehanou, Jutta Mari Adelin Jørgensen, Nuno Lunet and 14 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature human behaviour, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 11 countries.

Pascal Geldsetzer *Department of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA. pgeldsetzer@stanford.edu.ORCID http://orcid.org/0000-0002-8878-5505
Rebecca L Tisdale *Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0003-2749-6889
Lisa StehrHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0009-0009-4445-6150
Felix MichalikDepartment of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5589-5700
Julia LempHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1524-3641
Krishna K AryalDepartment for International Development/Nepal Health Sector Programme 3/Monitoring Evaluation and Operational Research, Abt Associates, Kathmandu, Nepal.ORCID http://orcid.org/0000-0003-0801-0775
Albertino DamascenoDepartment of Public and Forensic Health Sciences and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0003-0925-494X
Corine HouehanouLaboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
Jutta Mari Adelin JørgensenInstitute of Global Health, Dept of Public Health and Epidemiology, Copenhagen University, Copenhagen, Denmark.
Nuno LunetDepartment of Public and Forensic Health Sciences and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0003-1870-1430
Mary MayigeNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID http://orcid.org/0000-0003-4861-7870
Sahar Saeedi MoghaddamNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kibachio Joseph MwangiDivision of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya.ORCID http://orcid.org/0000-0003-3725-1762
Christian BommerHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Maja-Emilia MarcusCentre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.ORCID http://orcid.org/0000-0003-4904-2087
Michaela TheilmannHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-3413-232X
Cara EbertRWI-Leibniz Institute for Economic Research, Essen (Berlin Office), Berlin, Germany.ORCID http://orcid.org/0000-0002-5542-8712
Rifat AtunDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1531-5983
Justine Ina DaviesInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0001-6834-1838
David FloodDivision of Hospital Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
Jennifer Manne-GoehlerDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Jacqueline SeiglieDiabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Till BärnighausenHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Sebastian VollmerCentre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.ORCID http://orcid.org/0000-0002-7863-0462
Heidelberg University · DEHarvard University · USUniversidade do Porto · PTUniversity of Göttingen · DEAbt Associates (Nepal) · NPBrigham and Women's Hospital · USMinistry of Health · KENational Institute for Medical Research · TZRWI – Leibniz Institute for Economic Research · DEStanford Health Care · USTehran University of Medical Sciences · IRUniversité d'Abomey-Calavi · BJUniversity of Copenhagen · DKUniversity of Michigan · USUniversity of the Witwatersrand · ZAVA Palo Alto Health Care System · US

Funding

Alexander von Humboldt-Stiftung (Alexander von Humboldt Foundation) N/A
6 · The paper itself

Abstract

Evidence on cardiovascular disease (CVD) risk factor prevalence among adults living below the World Bank's international line for extreme poverty (those with income <$1.90 per day) globally is sparse. Here we pooled individual-level data from 105 nationally representative household surveys across 78 countries, representing 85% of people living in extreme poverty globally, and sorted individuals by country-specific measures of household income or wealth to identify those in extreme poverty. CVD risk factors (hypertension, diabetes, smoking, obesity and dyslipidaemia) were present among 17.5% (95% confidence interval (CI) 16.7-18.3%), 4.0% (95% CI 3.6-4.5%), 10.6% (95% CI 9.0-12.3%), 3.1% (95% CI 2.8-3.3%) and 1.4% (95% CI 0.9-1.9%) of adults in extreme poverty, respectively. Most were not treated for CVD-related conditions (for example, among those with hypertension earning <$1.90 per day, 15.2% (95% CI 13.3-17.1%) reported taking blood pressure-lowering medication). The main limitation of the study is likely measurement error of poverty level and CVD risk factors that could have led to an overestimation of CVD risk factor prevalence among adults in extreme poverty. Nonetheless, our results could inform equity discussions for resource allocation and design of effective interventions.

Indexed as

Cardiovascular DiseasesPovertyAdultAgedDiabetes MellitusFemaleGlobal HealthHeart Disease Risk FactorsHumansHypertensionMaleMiddle AgedObesityPrevalenceRisk FactorsSmoking

Identifiers

PMID38480824
OpenAlexW4392750750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.